SCHEMBL24465233

SCHEMBL24465233

CCC(C(=O)c1ccccc1C)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.57
HSD17B10 Q99714 1/20 0.57
ALDH1A1 P00352 2/20 0.49
GAA P10253 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ERCC5 P28715 1/20 0.45
FEN1 P39748 1/20 0.45
CRHBP P24387 2/20 0.44
CRHR2 Q13324 2/20 0.44
KCNQ2 O43526 2/20 0.44
HTT P42858 1/20 0.44
KDM4E B2RXH2 1/20 0.43
KDM4A O75164 1/20 0.43
BCHE P06276 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13267958 0.87 LMNA (0.44) LMNAHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL778073 0.81 ACP3 (0.46) GAASLC6A2SLC6A4SLC6A3SMN1; SMN2
SCHEMBL19041216 0.80 KMT2A (0.42) LMNAHSD17B10MEN1KMT2ASLC6A2
SCHEMBL1878466 0.79 SLC6A2 (0.48) HSD17B10ALDH1A1GAAMEN1KMT2A
SCHEMBL50454 0.78 LMNA (0.80) LMNAHSD17B10ALDH1A1POLBSMN1; SMN2
SCHEMBL15105762 0.78 L3MBTL1 (0.56) HSD17B10ALDH1A1KMT2ASLC6A2SLC6A4
SCHEMBL4935067 0.77 LMNA (0.61) LMNAHSD17B10ALDH1A1GAAMEN1
SCHEMBL10446352 0.77 SLC6A2 (0.49) MEN1KMT2ASLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL3647676 0.77 LMNA (0.77) LMNAHSD17B10ALDH1A1POLBSMN1; SMN2
SCHEMBL387303 0.77 LMNA (0.57) LMNAHSD17B10ALDH1A1KMT2ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4005567-A1 ISOFLAVONOID COMPOSITION WITH IMPROVED PHARMACOKINETICS Noxopharm Limited (AU) 2022-06-01 EP disclosed